Flexion Adds $20M in Series B on Newly Focused OA Pipeline
By Jennifer Boggs
Tuesday, December 4, 2012
Flexion Therapeutics Inc. is proving that, in drug development, it pays to stay flexible.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.